Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline

OBJECTIVE: To determine the effect of low-dose aspirin vs placebo on incident all-cause dementia, incident Alzheimer disease (AD), mild cognitive impairment (MCI), and cognitive decline in older individuals. METHODS: Aspirin in Reducing Events in the Elderly (ASPREE) was a double-blind, placebo-cont...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Ryan, Joanne, Storey, Elsdon, Murray, Anne M., Woods, Robyn L., Wolfe, Rory, Reid, Christopher M., Nelson, Mark R., Chong, Trevor T.J., Williamson, Jeff D., Ward, Stephanie A., Lockery, Jessica E., Orchard, Suzanne G., Trevaks, Ruth, Kirpach, Brenda, Newman, Anne B., Ernst, Michael E., McNeil, John J., Shah, Raj C.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Null Hypothesis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7455352/
https://ncbi.nlm.nih.gov/pubmed/32213642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000009277
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados